Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

MANDOM

TAIYO HOLDINGS

TOWA PHARMACEUTICAL

東京応化工業

Nichi-Iko Pharmaceutical

T&K TOKA

NIPPON KAYAKU

千寿製薬

小林製薬

KUMIAI CHEMICAL INDUSTRY

Kao

Sumitomo Bakelite

SAWAI PHARMACEUTICAL

TENMA

TOAGOSEI CO

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

メルコホールディングス

SANKEI CHEMICAL

PIONEER etc.

Hitachi Zosen etc.

Nittetsu Mining

Financial Indicator Details: NATOCO (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: NATOCO (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Net profit margin (Industry Average)	-1.80% (-12.05%)	4.36% (-0.50%)	3.96% (1.53%)	3.61% (-1.67%)	9.41% (3.05%)
C/F margin (Industry Average)	3.95% (-3.31%)	13.87% (8.51%)	6.02% (7.04%)	6.06% (6.35%)	10.99% (8.25%)
ROA (Industry Average)	-1.18% (0.52%)	3.18% (1.04%)	3.05% (2.07%)	2.84% (0.06%)	7.20% (2.71%)
ROE (Industry Average)	-1.57% (-1.43%)	4.30% (0.03%)	4.09% (2.96%)	3.74% (4.68%)	9.88% (4.57%)
Growth	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Equity growth (Industry Average)	- (-)	4.32% (5.01%)	4.42% (2.61%)	4.41% (-0.40%)	15.34% (8.16%)
Sales growth (Industry Average)	- (-)	18.03% (-2.67%)	9.05% (5.36%)	4.83% (1.07%)	17.00% (2.24%)
Net profit growth (Industry Average)	- (-)	384.50% (203.46%)	-0.71% (63.25%)	-4.44% (3.89%)	204.44% (90.38%)
Operating C/F growth (Industry Average)	- (-)	313.69% (275.10%)	-52.62% (35.09%)	5.42% (-6.09%)	112.22% (138.39%)
Stability	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Capital adequacy (Industry Average)	74.79% (53.80%)	73.99% (54.51%)	74.63% (55.00%)	76.11% (53.59%)	72.87% (56.30%)
Liquidity ratio (Industry Average)	270.29% (217.72%)	282.97% (225.70%)	304.45% (237.55%)	338.39% (239.89%)	286.76% (236.21%)
C/F ratio current liabilities (Industry Average)	874.63% (777.21%)	230.97% (303.31%)	487.71% (434.79%)	441.60% (929.73%)	290.21% (573.30%)
Quick ratio (Industry Average)	216.16% (138.97%)	228.03% (148.85%)	252.84% (156.17%)	279.83% (160.84%)	243.20% (156.81%)
Turnover	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Receivables turnover (Industry Average)	134.83day (83.89day)	125.09day (94.27day)	121.85day (93.96day)	118.75day (97.92day)	133.34day (98.27day)
Inventory turnover (Industry Average)	33.75day (54.45day)	29.19day (52.58day)	31.10day (52.64day)	33.74day (56.59day)	31.83day (58.68day)
Payable turnover (Industry Average)	80.68day (45.01day)	72.55day (49.82day)	76.57day (49.52day)	71.10day (52.10day)	70.21day (51.12day)
Working capita turnover (Industry Average)	87.91day (93.32day)	81.73day (97.02day)	76.39day (97.08day)	81.40day (102.41day)	94.96day (105.83day)
Stock etc.	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Market Value growth (Industry Average)	- (-)	- (34.57%)	- (1.49%)	- (-3.85%)	- (21.16%)
Dividend Yield (Industry Average)	- (3.20%)	- (1.93%)	- (2.17%)	- (2.45%)	1.24% (2.07%)
PER (Industry Average)	- (25.22%)	- (23.06%)	- (16.22%)	- (29.19%)	6.26% (16.58%)
PBR (Industry Average)	- (0.86%)	- (1.06%)	- (1.04%)	- (0.95%)	0.61% (1.08%)
PCFR (Industry Average)	- (7.18%)	- (9.23%)	- (-2.43%)	- (9.50%)	5.36% (7.56%)
PSR (Industry Average)	- (0.77%)	- (0.88%)	- (1.10%)	- (0.90%)	0.59% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-10-31	2010-10-31	2011-10-31
Net profit margin (Industry Average)	-2.14% (-5.37%)	4.68% (-10.69%)	4.41% (8.92%)
C/F margin (Industry Average)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	-1.32% (1.42%)	3.26% (-0.27%)	3.10% (1.53%)
ROE (Industry Average)	-1.77% (1.81%)	4.41% (3.42%)	4.16% (2.62%)
Growth	2009-10-31	2010-10-31	2011-10-31
Equity growth (Industry Average)	- (3.03%)	3.54% (0.04%)	3.26% (3.91%)
Sales growth (Industry Average)	- (-)	17.60% (0.75%)	3.26% (-1.74%)
Net profit growth (Industry Average)	- (43.48%)	357.38% (-47.04%)	-2.67% (62.14%)
Operating C/F growth (Industry Average)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-10-31	2010-10-31	2011-10-31
Capital adequacy (Industry Average)	74.67% (57.17%)	73.88% (55.93%)	74.52% (57.57%)
Liquidity ratio (Industry Average)	266.19% (266.94%)	275.94% (314.47%)	299.74% (233.84%)
C/F ratio current liabilities (Industry Average)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	208.79% (174.83%)	220.42% (228.06%)	241.19% (169.77%)
Turnover	2009-10-31	2010-10-31	2011-10-31
Receivables turnover (Industry Average)	134.59day (95.88day)	124.91day (98.58day)	121.48day (67.18day)
Inventory turnover (Industry Average)	34.78day (47.43day)	30.17day (50.67day)	32.27day (38.21day)
Payable turnover (Industry Average)	86.65day (51.13day)	78.29day (53.57day)	86.22day (34.24day)
Working capita turnover (Industry Average)	82.71day (92.19day)	76.78day (95.69day)	67.53day (71.15day)
Stock etc.	2009-10-31	2010-10-31	2011-10-31
Market Value growth (Industry Average)	- (3.11%)	- (-3.30%)	- (24.19%)
Dividend Yield (Industry Average)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	- (13.58%)	- (22.26%)	- (26.42%)
PBR (Industry Average)	- (1.17%)	- (1.08%)	- (1.54%)
PCFR (Industry Average)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	- (3.67%)	- (4.37%)	- (10.14%)

Financial Indicator Details: NATOCO

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Profitability
Net profit margin	-1.80%	4.36%	3.96%	3.61%	9.41%
C/F margin	3.95%	13.87%	6.02%	6.06%	10.99%
ROA	-1.18%	3.18%	3.05%	2.84%	7.20%
ROE	-1.57%	4.30%	4.09%	3.74%	9.88%
Recurring margin	2.71%	9.30%	8.88%	7.85%	17.05%
EBIT margin	0.80%	9.08%	8.73%	7.78%	16.93%
EBITDA margin	6.49%	13.77%	12.81%	11.63%	19.64%
NOPAT margin	0.48%	5.45%	5.24%	4.67%	10.15%
Sales SG rates	77.36%	72.98%	74.05%	75.73%	68.19%
Sales SG&A rates	19.28%	17.85%	17.43%	16.80%	15.80%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	5.69%	4.68%	4.07%	3.84%	2.71%
Capital expenditures net sales ratio	-5.21%	-4.88%	-2.67%	-1.95%	-7.94%
Indicator	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Growth
Growth rate of cash	-	20.84%	15.04%	8.48%	13.41%
Equity growth	-	4.32%	4.42%	4.41%	15.34%
Total assets growth	-	5.45%	3.53%	2.38%	20.47%
Sales growth	-	18.03%	9.05%	4.83%	17.00%
Net profit growth	-	384.50%	-0.71%	-4.44%	204.44%
Operating C/F growth	-	313.69%	-52.62%	5.42%	112.22%
Recurring profit growth	-	305.03%	4.20%	-7.32%	153.95%
EBIT growth	-	1,234.81%	4.81%	-6.51%	154.35%
EBITDA growth	-	150.18%	1.42%	-4.76%	97.53%
NOPAT growth	-	1,234.81%	4.81%	-6.51%	154.35%
Operating expenses growth	-	-	-	-	-
Indicator	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Stability
Capital adequacy	74.79%	73.99%	74.63%	76.11%	72.87%
Liquidity ratio	270.29%	282.97%	304.45%	338.39%	286.76%
C/F ratio current liabilities	874.63%	230.97%	487.71%	441.60%	290.21%
Quick ratio	216.16%	228.03%	252.84%	279.83%	243.20%
Fixed ratio	44.45%	39.97%	37.26%	33.23%	36.87%
D/E ratio	-	-	-	-	-
Loan to Value Ratio	-	-	-	-	-
Business investment C/F ratio	-131.65%	-35.22%	-44.29%	-32.25%	-72.26%
Liabilities with interest growth	-	-	-	-	-
Indicator	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Turnover
Cash turnover	138.39day	141.69day	149.48day	154.68day	149.93day
Receivables turnover	134.83day	125.09day	121.85day	118.75day	133.34day
Inventory turnover	33.75day	29.19day	31.10day	33.74day	31.83day
Fixed assets turnover	186.03day	147.87day	131.96day	117.22day	128.22day
Total asset turnover	559.48day	499.87day	474.56day	463.44day	477.21day
Payable turnover	80.68day	72.55day	76.57day	71.10day	70.21day
Capital turnover	58.55day	49.61day	45.49day	43.39day	37.08day
Equity turnover	418.46day	369.88day	354.17day	352.75day	347.76day
Working capita turnover	87.91day	81.73day	76.39day	81.40day	94.96day
Indicator	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Balance sheet
Cash etc.	¥ 3 B	¥ 4 B	¥ 5 B	¥ 5 B	¥ 6 B
Accounts receivable-trade	¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 5 B
Other Current Assets	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 8 B
Current Assets	¥ 9 B	¥ 10 B	¥ 11 B	¥ 12 B	¥ 14 B
Tangible Assets	¥ 5 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 5 B
Intangible Assets	¥ 160 M	¥ 130 M	¥ 134 M	¥ 201 M	¥ 202 M
Investment etc.	¥ 721 M	¥ 555 M	¥ 432 M	¥ 382 M	¥ 454 M
Total Assets	¥ 15 B	¥ 16 B	¥ 16 B	¥ 17 B	¥ 20 B
Current Liabilities	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 5 B
Fixed Liabilities	¥ 405 M	¥ 425 M	¥ 466 M	¥ 486 M	¥ 568 M
Liabilities with interest	-	-	-	-	-
Net Assets	¥ 11 B	¥ 12 B	¥ 12 B	¥ 13 B	¥ 15 B
Capital stock	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Capital surplus etc.	¥ 9 B	¥ 10 B	¥ 11 B	¥ 11 B	¥ 13 B
Liabilities and net assets	¥ 15 B	¥ 16 B	¥ 16 B	¥ 17 B	¥ 20 B
Indicator	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Income statement
Sales	¥ 10 B	¥ 11 B	¥ 13 B	¥ 13 B	¥ 16 B
Cost of Sales	¥ 7 B	¥ 8 B	¥ 9 B	¥ 10 B	¥ 10 B
Gross profit	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 5 B
Other income	¥ 63 M	¥ 59 M	¥ 79 M	¥ 71 M	¥ 182 M
SG&A	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Other expenses	¥ 499 M	¥ 519 M	¥ 536 M	¥ 443 M	¥ 1 B
Net income	¥ -183 M	¥ 521 M	¥ 518 M	¥ 495 M	¥ 1 B
Operating income	¥ 339 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Ordinary Income	¥ 274 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
EBITDA	¥ 658 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 3 B
Income before income taxes	¥ 93 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Depreciation	¥ 577 M	¥ 560 M	¥ 531 M	¥ 526 M	¥ 434 M
R&D expenses	-	-	-	-	-
Income taxes	¥ 189 M	¥ 460 M	¥ 494 M	¥ 425 M	¥ 1 B
Indicator	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Cash flow statement
Operating CF	¥ 401 M	¥ 1 B	¥ 786 M	¥ 829 M	¥ 1 B
Investment CF	¥ -291 M	¥ -1 B	¥ -343 M	¥ 25 M	¥ -1 B
Financial CF	¥ -102 M	¥ -102 M	¥ -117 M	¥ -117 M	¥ -117 M
Foreign Exchange Effects	¥ 4 M	¥ -6 M	¥ -251 K	¥ -132 K	¥ 280 M
Net Change in Cash	¥ 11 M	¥ 293 M	¥ 325 M	¥ 736 M	¥ 635 M
Free CF	¥ 109 M	¥ 402 M	¥ 443 M	¥ 854 M	¥ 473 M
Capital expenditures	¥ -528 M	¥ -584 M	¥ -348 M	¥ -267 M	¥ -1 B
Cash dividends paid	¥ -102 M	¥ -102 M	¥ -117 M	¥ -117 M	¥ -117 M
Repayment loans	-	-	-	-	-
Indicator	2009-10-31	2010-10-31	2011-10-31	2012-10-31	2013-10-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -102 M	¥ -102 M	¥ -117 M	¥ -117 M	¥ -117 M
Net income	¥ -183 M	¥ 521 M	¥ 518 M	¥ 495 M	¥ 1 B
Purchase of treasury stock	-	¥ -110 K	-	¥ -44 K	¥ -35 K
Other Change in Stockholders Equity	-	¥ -1 K	-	¥ -2 K	-
Other Change in Net Assets	¥ 116 M	¥ 84 M	¥ 135 M	¥ 180 M	¥ 638 M
Net Change in Net Assets	¥ -169 M	¥ 503 M	¥ 537 M	¥ 558 M	¥ 2 B

Financial Indicator Details: NATOCO

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-10-31	2010-10-31	2011-10-31
Profitability
Net profit margin	-2.14%	4.68%	4.41%
C/F margin	-	-	-
ROA	-1.32%	3.26%	3.10%
ROE	-1.77%	4.41%	4.16%
Recurring margin	1.46%	8.31%	8.07%
EBIT margin	-0.95%	8.02%	7.87%
EBITDA margin	0.72%	8.02%	7.87%
NOPAT margin	-0.57%	4.81%	4.72%
Sales SG rates	78.67%	73.85%	74.69%
Sales SG&A rates	19.46%	18.18%	17.85%
Sales R&D expenses rates	-	-	-
Sales depreciation rates	1.68%	-	-
Capital expenditures net sales ratio	-	-	-
Indicator	2009-10-31	2010-10-31	2011-10-31
Growth
Growth rate of cash	-	19.19%	14.82%
Equity growth	-	3.54%	3.26%
Total assets growth	-	4.65%	2.38%
Sales growth	-	17.60%	3.26%
Net profit growth	-	357.38%	-2.67%
Operating C/F growth	-	-	-
Recurring profit growth	-	567.57%	0.29%
EBIT growth	-	1,084.03%	1.37%
EBITDA growth	-	1,199.57%	1.37%
NOPAT growth	-	1,084.03%	1.37%
Operating expenses growth	-	-	-
Indicator	2009-10-31	2010-10-31	2011-10-31
Stability
Capital adequacy	74.67%	73.88%	74.52%
Liquidity ratio	266.19%	275.94%	299.74%
C/F ratio current liabilities	-	-	-
Quick ratio	208.79%	220.42%	241.19%
Fixed ratio	43.68%	39.50%	36.81%
D/E ratio	-	-	-
Loan to Value Ratio	-	-	-
Business investment C/F ratio	-	-	-
Liabilities with interest growth	-	-	-
Indicator	2009-10-31	2010-10-31	2011-10-31
Turnover
Cash turnover	144.98day	146.95day	163.39day
Receivables turnover	134.59day	124.91day	121.48day
Inventory turnover	34.78day	30.17day	32.27day
Fixed assets turnover	192.29day	153.10day	142.67day
Total asset turnover	589.37day	524.47day	520.00day
Payable turnover	86.65day	78.29day	86.22day
Capital turnover	64.28day	54.66day	52.93day
Equity turnover	440.14day	387.52day	387.50day
Working capita turnover	82.71day	76.78day	67.53day
Indicator	2009-10-31	2010-10-31	2011-10-31
Balance sheet
Cash etc.	¥ 3 B	¥ 4 B	¥ 5 B
Accounts receivable-trade	¥ 3 B	¥ 3 B	¥ 3 B
Other Current Assets	¥ 5 B	¥ 5 B	¥ 5 B
Current Assets	¥ 9 B	¥ 10 B	¥ 10 B
Tangible Assets	¥ 4 B	¥ 4 B	¥ 4 B
Intangible Assets	¥ 136 M	¥ 108 M	¥ 113 M
Investment etc.	¥ 891 M	¥ 814 M	¥ 601 M
Total Assets	¥ 14 B	¥ 15 B	¥ 15 B
Current Liabilities	¥ 3 B	¥ 3 B	¥ 3 B
Fixed Liabilities	¥ 387 M	¥ 405 M	¥ 441 M
Liabilities with interest	-	-	-
Net Assets	¥ 11 B	¥ 11 B	¥ 11 B
Capital stock	¥ 1 B	¥ 1 B	¥ 1 B
Capital surplus etc.	¥ 9 B	¥ 9 B	¥ 10 B
Liabilities and net assets	¥ 14 B	¥ 15 B	¥ 15 B
Indicator	2009-10-31	2010-10-31	2011-10-31
Income statement
Sales	¥ 9 B	¥ 10 B	¥ 11 B
Cost of Sales	¥ 7 B	¥ 8 B	¥ 8 B
Gross profit	¥ 1 B	¥ 2 B	¥ 2 B
Other income	¥ 88 M	¥ 78 M	¥ 103 M
SG&A	¥ 1 B	¥ 1 B	¥ 2 B
Other expenses	¥ 458 M	¥ 433 M	¥ 443 M
Net income	¥ -197 M	¥ 509 M	¥ 495 M
Operating income	¥ 172 M	¥ 865 M	¥ 836 M
Ordinary Income	¥ 135 M	¥ 903 M	¥ 905 M
EBITDA	¥ 67 M	¥ 871 M	¥ 883 M
Income before income taxes	¥ -71 M	¥ 885 M	¥ 895 M
Depreciation	¥ 155 M	-	-
R&D expenses	-	-	-
Income taxes	¥ 126 M	¥ 375 M	¥ 400 M
Indicator	2009-10-31	2010-10-31	2011-10-31
Cash flow statement
Operating CF	-	-	-
Investment CF	-	-	-
Financial CF	-	-	-
Foreign Exchange Effects	-	-	-
Net Change in Cash	-	-	-
Free CF	-	-	-
Capital expenditures	-	-	-
Cash dividends paid	-	-	-
Repayment loans	-	-	-
Indicator	2009-10-31	2010-10-31	2011-10-31
Shareowners' equity
Issuance of new shares	-	-	-
Dividends from surplus	¥ -102 M	¥ -102 M	¥ -117 M
Net income	¥ -197 M	¥ 509 M	¥ 495 M
Purchase of treasury stock	-	¥ -110 K	-
Other Change in Stockholders Equity	-	¥ -1 K	¥ -1 K
Other Change in Net Assets	¥ 44 M	¥ -11 M	¥ -2 M
Net Change in Net Assets	¥ -256 M	¥ 395 M	¥ 376 M

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: NATOCO (Annual )

Statement Type

Annual : NATOCO

First quarter : NATOCO

Second quarter : NATOCO

Third quarter : NATOCO

Analysis Menu

Outline : NATOCO

Statement : NATOCO

Rating : NATOCO

Indicator : NATOCO

Download : NATOCO

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Aichi - EDIUNET Prefectures

Aichiみよし市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
NATOCO	4627	OSE JASDAQ	Chemicals	10	Annual	AA

Related Company

TENMA (Sales ¥ 58 B)

Sumitomo Bakelite (Sales ¥ 183 B)

KANEKA (Sales ¥ 476 B)

千寿製薬 (Sales ¥ 28 B)

Toray Industries (Sales ¥ 1.5 T)

TAKASAGO INTERNATIONAL (Sales ¥ 118 B)

Dr.Ci:Labo (Sales ¥ 33 B)

Dainippon Sumitomo Pharma (Sales ¥ 347 B)

TOWA PHARMACEUTICAL (Sales ¥ 55 B)

TOAGOSEI CO (Sales ¥ 148 B)

Kao (Sales ¥ 1.0 T)

TAIYO HOLDINGS (Sales ¥ 36 B)

Aica Kogyo (Sales ¥ 101 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .